Detalles de la búsqueda
1.
The Impact of the Drying Process on the Antioxidant and Anti-Inflammatory Potential of Dried Ripe Coffee Cherry Pulp Soluble Powder.
Foods
; 13(7)2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38611418
2.
Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts.
FASEB J
; 25(8): 2538-50, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21507897
3.
5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity.
J Immunol
; 184(7): 3978-87, 2010 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20207999
4.
Enhancement of the Antioxidant Capacity of Thyme and Chestnut Honey by Addition of Bee Products.
Foods
; 11(19)2022 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36230193
5.
5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice.
Hepatology
; 51(3): 817-27, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20112424
6.
Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.
FASEB J
; 23(6): 1946-57, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19211925
7.
Protection from hepatic lipid accumulation and inflammation by genetic ablation of 5-lipoxygenase.
Prostaglandins Other Lipid Mediat
; 92(1-4): 54-61, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20227514
8.
Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor.
J Pharmacol Exp Ther
; 323(3): 778-86, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17766677
9.
Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA.
FASEB J
; 20(14): 2537-9, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17056761
10.
The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation.
FASEB J
; 19(9): 1120-2, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15876570
11.
Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells.
J Leukoc Biol
; 78(4): 871-8, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16033810
12.
Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4.
FASEB J
; 16(14): 1937-9, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12368230
13.
Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis.
FASEB J
; 17(12): 1745-7, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12958196
14.
Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites.
Br J Pharmacol
; 135(4): 891-900, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11861316
15.
5-Lipoxygenase (5-LO) is Involved in Kupffer Cell Survival. Possible Role of 5-LO Products in the Pathogenesis of Liver Fibrosis.
Comp Hepatol
; 3 Suppl 1: S19, 2004 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-14960171
16.
Renal effects of selective cyclooxygenase inhibition in experimental liver disease.
Adv Exp Med Biol
; 525: 133-6, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12751752
17.
Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols.
Am J Physiol Gastrointest Liver Physiol
; 296(3): G553-62, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19136384
18.
Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice.
J Lipid Res
; 49(12): 2513-23, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18645210
19.
Gene expression profiling of renal dysfunction in rats with experimental cirrhosis.
J Hepatol
; 45(2): 221-9, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16644059
20.
Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
Hepatology
; 41(3): 579-87, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15723448